Ketut Suastika Selected Research

Ketut Suastika Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 11/2023 - 10/2006
5	Obesity 06/2022 - 10/2006
4	Insulin Resistance 02/2024 - 01/2019
4	Diabetes Mellitus 01/2023 - 01/2018
4	Body Weight (Weight, Body) 01/2021 - 09/2011
3	Heart Failure 02/2021 - 11/2019
2	Inflammation (Inflammations) 02/2024 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 06/2023 - 09/2011
2	Prediabetic State (Prediabetes) 04/2022 - 02/2021
2	COVID-19 01/2022 - 11/2020
1	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2024
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Diabetes Complications 01/2023
1	Sarcopenia 06/2022
1	Glucose Intolerance 04/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Chronic Renal Insufficiency 02/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Albuminuria 01/2021
1	Disease Progression 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Ischemic Stroke 01/2021
1	Addison Disease (Addison's Disease) 01/2021
1	Abdominal Obesity 01/2020
1	Neoplasms (Cancer) 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Weight Gain 01/2020
1	Overweight 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018
1	Myocardial Infarction 01/2012
1	Isolated Systolic Hypertension 01/2012
1	Hyperglycemia 09/2011
1	Weight Loss (Weight Reduction) 10/2006
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2006
1	Gallbladder Diseases (Gall Bladder Disease) 10/2006

Drug/Important Bio-Agent (IBA)

12	Insulin (Novolin)FDA Link 02/2024 - 09/2011
9	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 04/2012
6	LipidsIBA 02/2024 - 04/2012
4	Blood Glucose (Blood Sugar)IBA 02/2024 - 01/2019
3	LDL CholesterolIBA 02/2024 - 01/2012
3	SodiumIBA 01/2021 - 11/2019
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 11/2019
2	HDL CholesterolIBA 02/2024 - 01/2019
2	C-Reactive ProteinIBA 02/2024 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 02/2024 - 01/2019
2	InsulinsIBA 06/2023 - 05/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2022
2	oxidized low density lipoproteinIBA 01/2022 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2020
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 11/2014
2	Hormones (Hormone)IBA 01/2021 - 10/2006
2	ApolipoproteinsIBA 01/2021 - 01/2019
2	CholesterolIBA 01/2019 - 01/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2024
1	imegliminIBA 11/2023
1	insulin degludecIBA 06/2023
1	Protamines (Protamine Sulfate)FDA Link 06/2023
1	Insulin Glargine (Lantus)FDA Link 06/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 02/2021
1	GlucocorticoidsIBA 01/2021
1	MineralocorticoidsIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 11/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	IodineIBA 01/2020
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2020
1	ThiazolidinedionesIBA 01/2020
1	Sterol Regulatory Element Binding Protein 1IBA 01/2020
1	Apolipoproteins AIBA 01/2019
1	Apolipoproteins B (ApoB)IBA 01/2019
1	Aldehyde Reductase (Aldose Reductase)IBA 01/2018
1	Uncoupling Protein 2IBA 04/2012
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2011

Therapy/Procedure

6	Therapeutics 01/2021 - 10/2006
3	Glycemic Control 02/2024 - 01/2020
1	Continuity of Patient Care 01/2020
1	Secondary Prevention 11/2019